CLINICAL_TRIALS
trial_result
· 2025-05-07
Clinical Trial Update: RWE Study Utilizing the Cala Trio Device in Patients With Essential Tremor [NA]
Summary
A real-world evidence study evaluating the Cala Trio neuromodulation device for essential tremor has completed, with results to be reported separately.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cala Health, Inc. | Conditions: Essential Tremor | NA | Status: COMPLETED